BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19530240)

  • 1. HER3 is required for the maintenance of neuregulin-dependent and -independent attributes of malignant progression in prostate cancer cells.
    Soler M; Mancini F; Meca-Cortés O; Sánchez-Cid L; Rubio N; López-Fernández S; Lozano JJ; Blanco J; Fernández PL; Thomson TM
    Int J Cancer; 2009 Dec; 125(11):2565-75. PubMed ID: 19530240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NRG-1 Stimulates Serum DJ-1 Increase in Breast Cancers.
    Wang Y; Zhang Y; Lu Q; Wang Y; Sun X; Zhang S
    Pathol Oncol Res; 2019 Jan; 25(1):71-79. PubMed ID: 28963699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen-independent prostate cancer cells circumvent EGFR inhibition by overexpression of alternative HER receptors and ligands.
    Carrión-Salip D; Panosa C; Menendez JA; Puig T; Oliveras G; Pandiella A; De Llorens R; Massaguer A
    Int J Oncol; 2012 Sep; 41(3):1128-38. PubMed ID: 22684500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuregulin-1 and human epidermal growth factor receptors 2 and 3 play a role in human lung development in vitro.
    Patel NV; Acarregui MJ; Snyder JM; Klein JM; Sliwkowski MX; Kern JA
    Am J Respir Cell Mol Biol; 2000 Apr; 22(4):432-40. PubMed ID: 10745024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.
    Lyne JC; Melhem MF; Finley GG; Wen D; Liu N; Deng DH; Salup R
    Cancer J Sci Am; 1997; 3(1):21-30. PubMed ID: 9072304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HER3 Is an Actionable Target in Advanced Prostate Cancer.
    Gil V; Miranda S; Riisnaes R; Gurel B; D'Ambrosio M; Vasciaveo A; Crespo M; Ferreira A; Brina D; Troiani M; Sharp A; Sheehan B; Christova R; Seed G; Figueiredo I; Lambros M; Dolling D; Rekowski J; Alajati A; Clarke M; Pereira R; Flohr P; Fowler G; Boysen G; Sumanasuriya S; Bianchini D; Rescigno P; Aversa C; Tunariu N; Guo C; Paschalis A; Bertan C; Buroni L; Ning J; Carreira S; Workman P; Swain A; Califano A; Shen MM; Alimonti A; Neeb A; Welti J; Yuan W; de Bono J;
    Cancer Res; 2021 Dec; 81(24):6207-6218. PubMed ID: 34753775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody targeting of HER2/HER3 signaling overcomes heregulin-induced resistance to PI3K inhibition in prostate cancer.
    Poovassery JS; Kang JC; Kim D; Ober RJ; Ward ES
    Int J Cancer; 2015 Jul; 137(2):267-77. PubMed ID: 25471734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Hsp90 inhibitor FW-04-806 displays potent antitumor effects in HER2-positive breast cancer cells as a single agent or in combination with lapatinib.
    Huang W; Wu QD; Zhang M; Kong YL; Cao PR; Zheng W; Xu JH; Ye M
    Cancer Lett; 2015 Jan; 356(2 Pt B):862-71. PubMed ID: 25449780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC-γ1 signalling in breast cancer cell migration and dissemination.
    Balz LM; Bartkowiak K; Andreas A; Pantel K; Niggemann B; Zänker KS; Brandt BH; Dittmar T
    J Pathol; 2012 Jun; 227(2):234-44. PubMed ID: 22262199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive activation of the neuregulin-1/ErbB receptor signaling pathway is essential for the proliferation of a neoplastic Schwann cell line.
    Frohnert PW; Stonecypher MS; Carroll SL
    Glia; 2003 Aug; 43(2):104-18. PubMed ID: 12838503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of ERBB family mRNA expression in breast carcinomas.
    Bièche I; Onody P; Tozlu S; Driouch K; Vidaud M; Lidereau R
    Int J Cancer; 2003 Sep; 106(5):758-65. PubMed ID: 12866037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-expression of HER2 and HER3 receptor tyrosine kinases enhances invasion of breast cells via stimulation of interleukin-8 autocrine secretion.
    Aceto N; Duss S; MacDonald G; Meyer DS; Roloff TC; Hynes NE; Bentires-Alj M
    Breast Cancer Res; 2012 Oct; 14(5):R131. PubMed ID: 23062209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward the prognostic significance and therapeutic potential of HER3 receptor tyrosine kinase in human colon cancer.
    Beji A; Horst D; Engel J; Kirchner T; Ullrich A
    Clin Cancer Res; 2012 Feb; 18(4):956-68. PubMed ID: 22142822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression through paracrine neuregulin 1/HER3 signalling.
    De Boeck A; Pauwels P; Hensen K; Rummens JL; Westbroek W; Hendrix A; Maynard D; Denys H; Lambein K; Braems G; Gespach C; Bracke M; De Wever O
    Gut; 2013 Apr; 62(4):550-60. PubMed ID: 22535374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
    Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
    J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of ligand-mediated HER2 activation in androgen-independent prostate cancer.
    Mendoza N; Phillips GL; Silva J; Schwall R; Wickramasinghe D
    Cancer Res; 2002 Oct; 62(19):5485-8. PubMed ID: 12359757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuregulin expression, function, and signaling in human ovarian cancer cells.
    Gilmour LM; Macleod KG; McCaig A; Sewell JM; Gullick WJ; Smyth JF; Langdon SP
    Clin Cancer Res; 2002 Dec; 8(12):3933-42. PubMed ID: 12473609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuregulin-1 induces cancer stem cell characteristics in breast cancer cell lines.
    Jeong H; Kim J; Lee Y; Seo JH; Hong SR; Kim A
    Oncol Rep; 2014 Sep; 32(3):1218-24. PubMed ID: 25018110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
    Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
    Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for phospholipase C-gamma-mediated signaling in tumor cell invasion.
    Kassis J; Moellinger J; Lo H; Greenberg NM; Kim HG; Wells A
    Clin Cancer Res; 1999 Aug; 5(8):2251-60. PubMed ID: 10473113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.